SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-21-134763
Filing Date
2021-11-05
Accepted
2021-11-05 08:30:35
Documents
7
Period of Report
2021-11-05

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2130750d3_6k.htm 6-K 18244
2 EXHIBIT 1.1 tm2130750d3_ex1-1.htm EX-1.1 217615
3 EXHIBIT 5.1 tm2130750d3_ex5-1.htm EX-5.1 30402
4 EXHIBIT 99.1 tm2130750d3_ex99-1.htm EX-99.1 12045
5 GRAPHIC tm2119736d15_ex5-1img001.jpg GRAPHIC 2544
6 GRAPHIC tm2119736d15_ex5-1img002.jpg GRAPHIC 1243
7 GRAPHIC tm2130750d3_ex99-1img001.jpg GRAPHIC 5268
  Complete submission text file 0001104659-21-134763.txt   292261
Mailing Address BREDGADE 34E COPENHAGEN K G7 1260
Business Address BREDGADE 34E COPENHAGEN K G7 1260 4531262615
Evaxion Biotech A/S (Filer) CIK: 0001828253 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39950 | Film No.: 211382429
SIC: 2836 Biological Products, (No Diagnostic Substances)